Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00342550
Other study ID # 999998016
Secondary ID OH98-CH-N016
Status Completed
Phase
First received
Last updated
Start date March 11, 1998
Est. completion date May 1, 2008

Study information

Verified date February 2023
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Preterm labor is a leading cause of perinatal morbidity and mortality. Several investigators have reported that ultrasound evaluation of the cervix can predict the risk of preterm delivery. Three-dimensional ultrasound may provide additional information about how to best counsel parents about the chances of premature birth. This technology has the capability for accurate volume measurements of irregular structures that is superior to conventional ultrasound. Therefore, it is possible that three-dimensional ultrasound methods may better characterize cervical changes and the risk for preterm delivery. Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.


Description:

Preterm labor is a leading cause of perinatal morbidity and mortality. Several investigators have reported that ultrasound evaluation of the cervix can predict the risk of preterm delivery. Three-dimensional ultrasound may provide additional information about how to best counsel parents about the chances of premature birth. This technology has the capability for accurate volume measurements of irregular structures that is superior to conventional ultrasound. Therefore, it is possible that three-dimensional ultrasound methods may better characterize cervical changes and the risk for preterm delivery. Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with maternal and fetal biological markers, placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.


Recruitment information / eligibility

Status Completed
Enrollment 648
Est. completion date May 1, 2008
Est. primary completion date May 1, 2008
Accepts healthy volunteers No
Gender Female
Age group 15 Years and older
Eligibility - INCLUSION CRITERIA - PRETERM LABOR AND INTACT MEMBRANES: 1. Singleton gestation; 2. Estimated gestational age between 20 and 35 weeks gestation; 3 Intact membranes; 4. Signed informed consent for voluntary participation and serial endovaginal scans. EXCLUSION CRITERIA - PRETERM LABOR AND INTACT MEMBRANES: 1. Absent fetal cardiac activity; 2. Desire not to have vaginal ultrasound scans. INCLUSION CRITERIA - PATIENTS AT RISK FOR PRETERM DELIVERY: 1. Estimated gestational age between 16 and < 24 weeks gestation; 2. Planned cerclage placement due to increased preterm labor risk (i.e., short cervix or dilated cervix); 3. Intact membranes; 4. Signed informed consent for voluntary participation and serial endovaginal scans. EXCLUSION CRITERIA - PATIENTS AT RISK FOR PRETERM DELIVERY: 1. Absent fetal cardiac activity; 2. Desire not to have vaginal ultrasound scans. INCLUSION CRITERIA - PATIENTS IN SPONTANEOUS LABOR AT TERM: 1. Term gestation (greater than 37 weeks); 2. Intact membranes; 3. Cervical dilatation less than 2 cm; 4. Signed informed consent for voluntary participation and serial endovaginal scans. EXCLUSION CRITERIA - PATIENTS IN SPONTANEOUS LABOR AT TERM: 1. Absent fetal cardiac activity; 2. Desire not to have vaginal ultrasound scans. INCLUSION CRITERIA - PATIENTS UNDERGOING ELECTIVE INDUCTION OF LABOR: 1. Term gestation (greater than 37 weeks); 2. Intact membranes; 3. Signed informed consent for voluntary participation and serial endovaginal scans. EXCLUSION CRITERIA - PATIENTS UNDERGOING ELECTIVE INDUCTION OF LABOR: 1. Absent fetal cardiac activity; 2. Desire not to have vaginal ultrasound scans.

Study Design


Locations

Country Name City State
United States Hutzel Women's Hospital Detroit Michigan

Sponsors (1)

Lead Sponsor Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Ayers JW, DeGrood RM, Compton AA, Barclay M, Ansbacher R. Sonographic evaluation of cervical length in pregnancy: diagnosis and management of preterm cervical effacement in patients at risk for premature delivery. Obstet Gynecol. 1988 Jun;71(6 Pt 1):939-44. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Document cervical volume and funneling changes in women with preterm labor. Determine the relationship between cervical volume and funneling changes to the risk of preterm delivery. Data analysis is ongoing Ongoing
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02523755 - Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia Phase 4